Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

How close are we to targeting the leukemia stem cell?

Pei S, Jordan CT.

Best Pract Res Clin Haematol. 2012 Dec;25(4):415-8. doi: 10.1016/j.beha.2012.10.003. Epub 2012 Oct 23. Review.

PMID:
23200537
2.

[Molecular targeted therapy for leukemic stem cells].

Kikushige Y.

Nihon Rinsho. 2015 May;73(5):811-5. Review. Japanese.

PMID:
25985636
3.

Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.

Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, Lagadinou ED, Corbett C, Ye H, Liesveld JL, O'Dwyer KM, Li Z, Shi L, Greninger P, Settleman J, Benes C, Hagen FK, Munger J, Crooks PA, Becker MW, Jordan CT.

J Biol Chem. 2013 Nov 22;288(47):33542-58. doi: 10.1074/jbc.M113.511170. Epub 2013 Oct 2.

4.

Targeting the acute myeloid leukemia stem cells.

Krause A, Luciana M, Krause F, Rego EM.

Anticancer Agents Med Chem. 2010 Feb;10(2):104-10. Review.

PMID:
20184541
5.

Eradication of leukemia stem cells as a new goal of therapy in leukemia.

Ravandi F, Estrov Z.

Clin Cancer Res. 2006 Jan 15;12(2):340-4. Review.

6.

Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.

Duechler M, Stańczyk M, Czyz M, Stepnik M.

Cancer Chemother Pharmacol. 2008 Apr;61(5):727-37. Epub 2007 Jun 27.

PMID:
17594095
7.
8.

Leukemic stem cells: where do they come from?

Passegué E, Weisman IL.

Stem Cell Rev. 2005;1(3):181-8. Review.

PMID:
17142854
9.

Metabolism and the leukemic stem cell.

Abdel-Wahab O, Levine RL.

J Exp Med. 2010 Apr 12;207(4):677-80. doi: 10.1084/jem.20100523. Epub 2010 Apr 5.

10.

Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide.

Wen J, You KR, Lee SY, Song CH, Kim DG.

J Biol Chem. 2002 Oct 11;277(41):38954-64. Epub 2002 Jul 31.

11.

The leukemic stem cell.

Jordan CT.

Best Pract Res Clin Haematol. 2007 Mar;20(1):13-8. Review.

12.

Pathways involved in the evolution of leukemic stem cells.

Zhang PY, Yang YJ, Fu CM, Xiang LL, Wang Q, Li XL.

Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1356-63. Review.

13.

Considerations for targeting malignant stem cells in leukemia.

Guzman ML, Jordan CT.

Cancer Control. 2004 Mar-Apr;11(2):97-104. Review.

14.

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Misaghian N, Ligresti G, Steelman LS, Bertrand FE, Bäsecke J, Libra M, Nicoletti F, Stivala F, Milella M, Tafuri A, Cervello M, Martelli AM, McCubrey JA.

Leukemia. 2009 Jan;23(1):25-42. doi: 10.1038/leu.2008.246. Epub 2008 Sep 18. Review.

15.

Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.

Kim YR, Eom JI, Kim SJ, Jeung HK, Cheong JW, Kim JS, Min YH.

J Pharmacol Exp Ther. 2010 Nov;335(2):389-400. doi: 10.1124/jpet.110.169367. Epub 2010 Aug 10.

16.

Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.

Tsiftsoglou AS, Bonovolias ID, Tsiftsoglou SA.

Pharmacol Ther. 2009 Jun;122(3):264-80. doi: 10.1016/j.pharmthera.2009.03.001. Epub 2009 Mar 21. Review.

PMID:
19306896
17.

Leukemia stem cells.

Luo L, Han ZC.

Int J Hematol. 2006 Aug;84(2):123-7. Review.

PMID:
16926133
18.

Expression and functional role of HERG1, K+ channels in leukemic cells and leukemic stem cells.

Li H, Liu L, Guo T, Zhang J, Li X, Du W, Liu W, Chen X, Huang S.

J Huazhong Univ Sci Technolog Med Sci. 2007 Jun;27(3):257-60.

PMID:
17641836
19.

Leukemic stem cells: from metabolic pathways and signaling to a new concept of drug resistance targeting.

Styczynski J, Drewa T.

Acta Biochim Pol. 2007;54(4):717-26. Epub 2007 Dec 13. Review.

20.

Hematological malignancies: disease pathophysiology of leukemic stem cells.

Ramdass B, Chowdhary A, Koka PS.

J Stem Cells. 2013;8(3-4):151-87. doi: jsc.2014.8.3/4.151. Review.

PMID:
24699024

Supplemental Content

Support Center